CSPC Pharmaceutical Group Limited (00867) has successfully completed its secondary listing on the Singapore Exchange Mainboard through an introduction method. The company's ordinary shares commenced trading today under the stock code "8A8", with each board lot comprising 100 shares. Concurrently, these shares will maintain their primary listing status and continue trading on the Main Board of The Stock Exchange of Hong Kong Limited. This strategic move expands the pharmaceutical firm's investor base while preserving its core market presence in Hong Kong.